Lisa Mucha

1.3k total citations
36 papers, 976 citations indexed

About

Lisa Mucha is a scholar working on Economics and Econometrics, Psychiatry and Mental health and General Health Professions. According to data from OpenAlex, Lisa Mucha has authored 36 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Economics and Econometrics, 11 papers in Psychiatry and Mental health and 7 papers in General Health Professions. Recurrent topics in Lisa Mucha's work include Health Systems, Economic Evaluations, Quality of Life (11 papers), Dementia and Cognitive Impairment Research (10 papers) and Geriatric Care and Nursing Homes (4 papers). Lisa Mucha is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (11 papers), Dementia and Cognitive Impairment Research (10 papers) and Geriatric Care and Nursing Homes (4 papers). Lisa Mucha collaborates with scholars based in United States, Canada and United Kingdom. Lisa Mucha's co-authors include Walter L. Straus, A. Mark Fendrick, Michael E. Chernew, A. Regula Herzog, Kenneth M. Langa, Robert J. Willis, Robert B. Wallace, Mary Beth Ofstedal, Mohammed U. Kabeto and Judith J. Stephenson and has published in prestigious journals such as Gastroenterology, Neurology and Journal of the American Geriatrics Society.

In The Last Decade

Lisa Mucha

36 papers receiving 943 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lisa Mucha United States 14 333 259 173 140 137 36 976
Joseph Williams United Kingdom 14 466 1.4× 302 1.2× 126 0.7× 95 0.7× 164 1.2× 17 1.2k
AT Jotheeswaran United Kingdom 10 478 1.4× 382 1.5× 86 0.5× 123 0.9× 91 0.7× 12 1.1k
Renata Sousa United Kingdom 8 372 1.1× 270 1.0× 76 0.4× 106 0.8× 71 0.5× 10 870
Alain Grand France 19 434 1.3× 374 1.4× 155 0.9× 208 1.5× 73 0.5× 45 1.2k
Chek Hooi Wong Singapore 14 243 0.7× 170 0.7× 107 0.6× 82 0.6× 203 1.5× 45 958
Alain Colvez France 20 219 0.7× 364 1.4× 140 0.8× 79 0.6× 271 2.0× 63 1.4k
Janne Martikainen Finland 22 393 1.2× 253 1.0× 349 2.0× 68 0.5× 77 0.6× 104 1.4k
Linda Barnes United Kingdom 13 486 1.5× 254 1.0× 85 0.5× 65 0.5× 117 0.9× 21 1.1k
John Cullen Australia 16 508 1.5× 249 1.0× 86 0.5× 54 0.4× 185 1.4× 45 1.2k
Hagen Sandholzer Germany 17 194 0.6× 222 0.9× 87 0.5× 48 0.3× 93 0.7× 61 884

Countries citing papers authored by Lisa Mucha

Since Specialization
Citations

This map shows the geographic impact of Lisa Mucha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisa Mucha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisa Mucha more than expected).

Fields of papers citing papers by Lisa Mucha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisa Mucha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisa Mucha. The network helps show where Lisa Mucha may publish in the future.

Co-authorship network of co-authors of Lisa Mucha

This figure shows the co-authorship network connecting the top 25 collaborators of Lisa Mucha. A scholar is included among the top collaborators of Lisa Mucha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisa Mucha. Lisa Mucha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ching, Christina B., Lisa Mucha, Nuno Antunes, et al.. (2023). The real world experience of pediatric primary hyperoxaluria patients in the PEDSnet clinical research network. European Journal of Pediatrics. 182(9). 4027–4036. 3 indexed citations
2.
Atsou, Kokuvi, Larry Ereshefsky, Mélanie Brignone, et al.. (2020). Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant. Expert Review of Pharmacoeconomics & Outcomes Research. 21(1). 29–42. 2 indexed citations
3.
MacEwan, Joanna P., et al.. (2020). Modeling the impact of patient treatment preference on health outcomes in relapsing-remitting multiple sclerosis. Journal of Medical Economics. 23(5). 474–483. 6 indexed citations
4.
Opler, Mark, et al.. (2019). <p>Patient attitudes toward and goals for MDD treatment: a survey study</p>. Patient Preference and Adherence. Volume 13. 959–967. 16 indexed citations
5.
McCue, Maggie, Sagar V. Parikh, Lisa Mucha, et al.. (2019). Adapting the Goal Attainment Approach for Major Depressive Disorder. Neurology and Therapy. 8(2). 167–176. 13 indexed citations
6.
Bonafede, Machaon, et al.. (2018). Cost sharing and branded antidepressant initiation among patients treated with generics.. PubMed. 24(4). 180–186. 4 indexed citations
7.
8.
Rockwood, Kenneth, et al.. (2013). Staging Dementia From Symptom Profiles on a Care Partner Website. Journal of Medical Internet Research. 15(8). e145–e145. 13 indexed citations
9.
Malone, Daniel C., Trent P. McLaughlin, Peter Wahl, et al.. (2009). Burden of Alzheimer's disease and association with negative health outcomes.. PubMed. 15(8). 481–8. 42 indexed citations
10.
Malone, Daniel C., et al.. (2009). P2‐071: Increased risk of serious comorbidities in a cohort of AD patients compared to a similar non‐AD cohort. Alzheimer s & Dementia. 5(4S_Part_9). 3 indexed citations
11.
Mucha, Lisa, et al.. (2008). Impact of compliance and persistence with bisphosphonate therapy on health care costs and utilization. Osteoporosis International. 19(10). 1421–1429. 35 indexed citations
12.
Mucha, Lisa, et al.. (2008). Comparison of Cholinesterase Inhibitor Utilization Patterns and Associated Health Care Costs in Alzheimer's Disease. Journal of Managed Care Pharmacy. 14(5). 451–461. 53 indexed citations
13.
Mark, Tami L., et al.. (2007). Racial differences in switching, augmentation, and titration of lipid-lowering agents by Medicare/Medicaid dual-eligible patients.. PubMed. 13 Suppl 3. S72–9. 16 indexed citations
14.
Mucha, Lisa, et al.. (2006). Meta-analysis of disease risk associated with smoking, by gender and intensity of smoking. Gender Medicine. 3(4). 279–291. 123 indexed citations
15.
Mucha, Lisa, et al.. (2006). Per-patient-per-month Drug Costs in Medicare Part D Protected Classes. PharmacoEconomics. 24(S3). 79–84. 9 indexed citations
16.
Lapane, Kate L., et al.. (2001). Effect of Nonsteroidal Anti‐Inflammatory Drug Use on the Rate of Gastrointestinal Hospitalizations Among People Living in Long‐Term Care. Journal of the American Geriatrics Society. 49(5). 577–584. 34 indexed citations
17.
Langa, Kenneth M., Michael E. Chernew, Mohammed U. Kabeto, et al.. (2001). National estimates of the quantity and cost of informal caregiving for the elderly with dementia. Journal of General Internal Medicine. 16(11). 770–778. 358 indexed citations
18.
Langa, Kenneth M., Michael E. Chernew, Mohammed U. Kabeto, et al.. (2001). National Estimates of the Quantity and Cost of Informal Caregiving for the Elderly with Dementia*. Journal of General Internal Medicine. 16(11). 770–778. 18 indexed citations
19.
Mucha, Lisa, et al.. (2000). NSAID and concomitant gastrointestinal drug use among cases and controls in a managed care population. Gastroenterology. 118(4). A718–A718. 2 indexed citations
20.
Abbott, Thomas A., et al.. (1999). Efficient Patient Identification Strategies for Women with Osteoporosis. Journal of Clinical Densitometry. 2(3). 223–231. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026